학술논문

Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma

Document Type

Article

Author

Subbiah, V.; Chawla, S.P.; Conley, A.P.; Wilky, B.A.; Tolcher, A.; Lakhani, N.J.; Berz, D.; Andrianov, V.; Crago, W.; Holcomb, M.; Hussain, A.; Veldstra, C.; Kalabus, J.; O’Neill, B.; Senne, L.; Rowell, E.; Heidt, A.B.; Willis, K.M.; Eckelman, B.P.

Source

In: Clinical Cancer Research. (Clinical Cancer Research, 15 August 2023, 29(16):2988-3003)

Subject

Language

English

ISSN

15573265
10780432

Online Access

Full Text (ECC - 개별구독 전자저널) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송